ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 359415 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 359415; 2) Community: the network communities that were significantly associated with the response to NSC 359415; 3) Molecule: the relationships between components within communities and NSC 359415; 4) MDR: the compounds that were significantly associated with the NSC 359415.

NSC Compound Enrichment Correlation
NSC 625878 Null 0.0171490505199911 0.45959444
NSC 629868 Null 0.0171490505199911 -0.12758629
NSC 637993 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[2-(diethylamino) ethylamino]-8-methoxy-1-methyl-, dihydrochloride 0.0171490505199911 0.23810146
NSC 638748 Tetrakis(8-chinolineolato)titanium(IV)-tetrahydrochloride 0.0171490505199911 0.3221758
NSC 645317 Sanguilutine pseudobase 0.0171490505199911 0.13017544
NSC 658443 2-Chloro-3-amino-5,8-dihydoxy-1,4-naphthoquinone 0.0171490505199911 0.18480915
NSC 663285 6-N-(Aminoethyl-2-(4-morpholino))-6-chloro-5,8-quinolinedione 0.0171490505199911 0.23761337
NSC 666707 2-bishydroxyimino-4-(4-morpholinyl)-1-phenylmethyl bicyclo[2.2.2]octane 0.0171490505199911 -0.069014879
NSC 673455 Null 0.0171490505199911 0.3647572
NSC 679002 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl]-, diethyl ester, cis- 0.0171490505199911 0.31540879
Total:139  Current:73    [First] [Prev] [Next] [Last]